MAPT and tauopathy: The downstream clinical phenotypes that differ across tauopathies appear to be dependent on the differential neuronal and regional vulnerabilities specific to each tauopathy, and this may be dictated by the type of tau aggregate that forms early in disease and continues to propagate in a type-specific manner.